King Adam 4
4 · QSAM Biosciences, Inc. · Filed Jun 29, 2023
Insider Transaction Report
Form 4
King Adam
Chief Financial Officer
Transactions
- Award
Common Stock
2023-06-23+20,910→ 20,910 total - Award
Common Stock
2023-06-23+2,040→ 22,950 total - Award
Options to buy common stock
2022-03-03+12,500→ 12,500 totalExercise: $10.00Exp: 2032-03-03→ Common Stock (12,500 underlying)
Footnotes (3)
- [F1]This award of shares is being made pursuant to the Issuer's restricted stock award agreement and is subject to a vesting schedule, such that a portion or all of this award of restricted stock may be forfeited in the future if certain milestones are not met.
- [F2]Shares acquired upon conversion of deferred salary of $10,200.
- [F3]As of 3/31/2023, 9,375 shares vested based on performance. The balance of the shares will vest in 36 monthly installments commencing March 1, 2023.